Ole Bent Samuelsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ole Bent Samuelsen has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Øivind Bergh
Institute of Marine Research, Bergen, Norway
5 shared publications A Ervik
1 shared publicationA. Ervik
Department of Aquaculture, Institute of Marine Research, Bergen, Norway
1 shared publicationA. Jelmert
Institute of Marine Research, Austevoll Aquaculture Research Station, Storebø, Norway
1 shared publicationA. Levsen
1 shared publicationA. Maage
1 shared publication
Latest Publications
- 10 December 2015
- Published by Springer Nature in Bulletin of Environmental Contamination and Toxicology
- Vol. 96 (2) , 224-228
Persistence and Stability of Teflubenzuron and Diflubenzuron When Associated to Organic Particles in Marine Sediment
The persistence and stability of the oral administered anti salmon-lice drugs teflubenzuron and diflubenzuron were tested when associated to organic material as faecal particles from Atlantic salmon and medicated food pellets. This laboratory study was performed in seawater under aerobic conditions, at 7°C in the dark and showed that both compounds were remarkably persistent and stable since no significant reduction in the concentrations of flubenzurons in sediment were seen after 24 weeks. Therefore neither chemical or microbial degradation nor outwashing seems to be important pathways for these drugs to disappear from sediment under fish farms. Thus, it is more likely that the decrease of flubenzurons from marine sediments described in field investigations is caused by either bioturbation, resuspension of organic particles or a combination of these.
- 10 December 2015
- Published by Springer Nature in Bulletin of Environmental Contamination and Toxicology
- Vol. 96 (2) , 224-228
Persistence and Stability of Teflubenzuron and Diflubenzuron When Associated to Organic Particles in Marine Sediment
The persistence and stability of the oral administered anti salmon-lice drugs teflubenzuron and diflubenzuron were tested when associated to organic material as faecal particles from Atlantic salmon and medicated food pellets. This laboratory study was performed in seawater under aerobic conditions, at 7°C in the dark and showed that both compounds were remarkably persistent and stable since no significant reduction in the concentrations of flubenzurons in sediment were seen after 24 weeks. Therefore neither chemical or microbial degradation nor outwashing seems to be important pathways for these drugs to disappear from sediment under fish farms. Thus, it is more likely that the decrease of flubenzurons from marine sediments described in field investigations is caused by either bioturbation, resuspension of organic particles or a combination of these.
- Open Access
- 1 April 2014
- Published by Elsevier in Aquatic Toxicology
- Vol. 149, 8-15
Mortality and deformities in European lobster (Homarus gammarus) juveniles exposed to the anti-parasitic drug teflubenzuron
- 1 April 2014
- Published by Elsevier in Aquatic Toxicology
- Vol. 149, 8-15
Open AccessMortality and deformities in European lobster (Homarus gammarus) juveniles exposed to the anti-parasitic drug teflubenzuron
- Open Access
- 17 February 2012
- Published by Inter-Research Science Center in Diseases of Aquatic Organisms
- Vol. 98 (1) , 57-62
Antimicrobial susceptibility of Francisella noatunensis subsp. noatunensis strains isolated from Atlantic cod Gadus morhua in Norway
A total of 30 isolates of Francisella noatunensis subsp. noatunensis isolated from Atlantic cod Gadus morhua L. were tested for susceptibility, in the form of minimal inhibitory concentration (MIC) values, against the following antibacterial agents: flumequine, oxolinic acid, ciprofloxacin, florfenicol, oxytetracycline, erythromycin, streptomycin sulphate, trimetoprim/ sulphadiazine and rifampin. All the isolates had a low susceptibility to oxytetracycline, trimetoprim/ sulphadiazine (Tribrissen®), erythromycin, ciprofloxacin and streptomycin with MIC values of 64, 64 to 128, 16, 8 and 32 to 128 μg ml−1, respectively. The strains were, on the other hand, susceptible to florfenicol, oxolinic acid, flumequine and rifampin with MIC values of 0.5, 0.25, 0.25 and 0.25 to 1 μg ml−1, respectively
- 17 February 2012
- Published by Inter-Research Science Center in Diseases of Aquatic Organisms
- Vol. 98 (1) , 57-62
Open AccessAntimicrobial susceptibility of Francisella noatunensis subsp. noatunensis strains isolated from Atlantic cod Gadus morhua in Norway
A total of 30 isolates of Francisella noatunensis subsp. noatunensis isolated from Atlantic cod Gadus morhua L. were tested for susceptibility, in the form of minimal inhibitory concentration (MIC) values, against the following antibacterial agents: flumequine, oxolinic acid, ciprofloxacin, florfenicol, oxytetracycline, erythromycin, streptomycin sulphate, trimetoprim/ sulphadiazine and rifampin. All the isolates had a low susceptibility to oxytetracycline, trimetoprim/ sulphadiazine (Tribrissen®), erythromycin, ciprofloxacin and streptomycin with MIC values of 64, 64 to 128, 16, 8 and 32 to 128 μg ml−1, respectively. The strains were, on the other hand, susceptible to florfenicol, oxolinic acid, flumequine and rifampin with MIC values of 0.5, 0.25, 0.25 and 0.25 to 1 μg ml−1, respectively
- 18 October 2011
- Published by Wiley in Journal of Fish Diseases
- Vol. 34 (12) , 927-930
Efficacy of florfenicol in the treatment of bacterial infections in halibut, Hippoglossus hippoglossus (L.), larvae
- 18 October 2011
- Published by Wiley in Journal of Fish Diseases
- Vol. 34 (12) , 927-930
Efficacy of florfenicol in the treatment of bacterial infections in halibut, Hippoglossus hippoglossus (L.), larvae
- 5 May 2011
- Published by Wiley in Journal of Fish Diseases
- Vol. 34 (6) , 453-457
An evaluation of the duration of efficacy of emamectin benzoate in the control of Caligus curtus Müller infestations in Atlantic cod, Gadus morhua L.
- 5 May 2011
- Published by Wiley in Journal of Fish Diseases
- Vol. 34 (6) , 453-457
An evaluation of the duration of efficacy of emamectin benzoate in the control of Caligus curtus Müller infestations in Atlantic cod, Gadus morhua L.
- 16 November 2010
- Published by Hindawi Limited in Journal of Applied Ichthyology
- Vol. 27 (1) , 57-60
Feed intake and tissue distribution of florfenicol in cod (Gadus morhua) administered feed with different fat contents
- 16 November 2010
- Published by Hindawi Limited in Journal of Applied Ichthyology
- Vol. 27 (1) , 57-60
Feed intake and tissue distribution of florfenicol in cod (Gadus morhua) administered feed with different fat contents
- 11 November 2010
- Published by Hindawi Limited in Aquaculture Research
- Vol. 42 (8) , 1110-1116
Evaluating bioencapsulation of florfenicol in rotifers (Brachionus plicatilis)
- 11 November 2010
- Published by Hindawi Limited in Aquaculture Research
- Vol. 42 (8) , 1110-1116
Evaluating bioencapsulation of florfenicol in rotifers (Brachionus plicatilis)
- 14 January 2010
- Published by Wiley in Journal of Fish Diseases
- Vol. 33 (2) , 137-142
A single‐dose pharmacokinetic study of emamectin benzoate in cod, Gadus morhua L., held in sea water at 9 °C
The pharmacokinetic profile of the antiparasitic agent emamectin benzoate was studied in plasma after intravenous (i.v.) injection and in plasma, muscle and skin following oral (p.o.) administration to cod, Gadus morhua, held in sea water at 9 degrees C and weighing 100-200 g. Following i.v. injection, the plasma drug concentration-time profile showed two distinct phases. The plasma distribution half-life (t(1/2)alpha) was estimated as 2.5 h, the elimination half-life (t(1/2)beta) as 216 h, the total body clearance (Cl(T)) as 0.0059 L kg(-1) h(-1) and mean residence time (MRT) as 385 h. The volume of distribution at steady state, V(d(ss)), was calculated to be 1.839 L kg(-1). Following p.o. administration the peak plasma concentration (C(max)) was 15 ng mL(-1), the time to peak plasma concentration (T(max)) was 89 h and t(1/2)beta was 180 h. The highest concentration in muscle (21 ng g(-1)) was measured after 7 days and t(1/2)beta was calculated to be 247 h. For skin, a peak concentration of 28 ng g(-1) at 3 days was observed and a t(1/2)beta of 235 h was determined. The bioavailability following p.o. administration was calculated to be 38%.
- 14 January 2010
- Published by Wiley in Journal of Fish Diseases
- Vol. 33 (2) , 137-142
A single‐dose pharmacokinetic study of emamectin benzoate in cod, Gadus morhua L., held in sea water at 9 °C
The pharmacokinetic profile of the antiparasitic agent emamectin benzoate was studied in plasma after intravenous (i.v.) injection and in plasma, muscle and skin following oral (p.o.) administration to cod, Gadus morhua, held in sea water at 9 degrees C and weighing 100-200 g. Following i.v. injection, the plasma drug concentration-time profile showed two distinct phases. The plasma distribution half-life (t(1/2)alpha) was estimated as 2.5 h, the elimination half-life (t(1/2)beta) as 216 h, the total body clearance (Cl(T)) as 0.0059 L kg(-1) h(-1) and mean residence time (MRT) as 385 h. The volume of distribution at steady state, V(d(ss)), was calculated to be 1.839 L kg(-1). Following p.o. administration the peak plasma concentration (C(max)) was 15 ng mL(-1), the time to peak plasma concentration (T(max)) was 89 h and t(1/2)beta was 180 h. The highest concentration in muscle (21 ng g(-1)) was measured after 7 days and t(1/2)beta was calculated to be 247 h. For skin, a peak concentration of 28 ng g(-1) at 3 days was observed and a t(1/2)beta of 235 h was determined. The bioavailability following p.o. administration was calculated to be 38%.
- 24 November 2006
- Published by Wiley in Journal of Fish Diseases
- Vol. 29 (12) , 737-742
Treating experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua L., with florfenicol
This study was performed to determine the efficacy of orally administered florfenicol in the treatment of experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua. The L. anguillarum strain HI-610 was used. This strain has a minimal inhibitory concentration value of 0.5 mg L−1 against florfenicol. Fifteen groups of 40 fish each were challenged by bath with 1.7 × 105 CFU mL−1 for 1 h. Three days following challenge, medication with florfenicol was introduced in 12 of the groups. The dosages used were 10 mg kg−1 day−1 for 10 consecutive days in marine or salmonid pellets, 10 mg kg−1 day−1 for five consecutive days in marine pellets or administered at days 1, 2, 4, 6 and 8 following initiation of treatment. Among challenged unmedicated fish mortality started at day 3 post-challenge reaching a final cumulative mortality of 77% at day 15. The experiment was terminated at day 26. In the medicated groups, the majority of deaths occurred from days 3–7 post-challenge reaching final cumulative mortalities of 31% and 52%, respectively, for the fish given marine and salmonid pellets for 10 consecutive days. The fish treated with medicated marine pellets for five consecutive days and at days 1, 2, 4, 6 and 8 (sequential feeding) following initiation of treatment had cumulative mortalities of 52% and 38%, respectively. Survival of medicated fish in all groups was significantly (P < 0.005) greater than survival of challenged unmedicated fish. Furthermore, a significant difference (P < 0.001) in survival was found between fish treated for 10 consecutive days using marine pellets and the groups using marine pellets for five consecutive days and salmonid pellets for 10 consecutive days. Twenty four hours following last medication, six fish had mean plasma concentrations of 3.3 ± 1.7 and 3.5 ± 2.8 μg mL−1, respectively, in fish treated for 10 consecutive days using marine and salmonid pellets. Corresponding values for fish treated for five consecutive days and by sequential feeding were 2.2 ± 2.3 and 1.7 ± 0.7 μg mL−1, respectively.
- 24 November 2006
- Published by Wiley in Journal of Fish Diseases
- Vol. 29 (12) , 737-742
Treating experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua L., with florfenicol
This study was performed to determine the efficacy of orally administered florfenicol in the treatment of experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua. The L. anguillarum strain HI-610 was used. This strain has a minimal inhibitory concentration value of 0.5 mg L−1 against florfenicol. Fifteen groups of 40 fish each were challenged by bath with 1.7 × 105 CFU mL−1 for 1 h. Three days following challenge, medication with florfenicol was introduced in 12 of the groups. The dosages used were 10 mg kg−1 day−1 for 10 consecutive days in marine or salmonid pellets, 10 mg kg−1 day−1 for five consecutive days in marine pellets or administered at days 1, 2, 4, 6 and 8 following initiation of treatment. Among challenged unmedicated fish mortality started at day 3 post-challenge reaching a final cumulative mortality of 77% at day 15. The experiment was terminated at day 26. In the medicated groups, the majority of deaths occurred from days 3–7 post-challenge reaching final cumulative mortalities of 31% and 52%, respectively, for the fish given marine and salmonid pellets for 10 consecutive days. The fish treated with medicated marine pellets for five consecutive days and at days 1, 2, 4, 6 and 8 (sequential feeding) following initiation of treatment had cumulative mortalities of 52% and 38%, respectively. Survival of medicated fish in all groups was significantly (P < 0.005) greater than survival of challenged unmedicated fish. Furthermore, a significant difference (P < 0.001) in survival was found between fish treated for 10 consecutive days using marine pellets and the groups using marine pellets for five consecutive days and salmonid pellets for 10 consecutive days. Twenty four hours following last medication, six fish had mean plasma concentrations of 3.3 ± 1.7 and 3.5 ± 2.8 μg mL−1, respectively, in fish treated for 10 consecutive days using marine and salmonid pellets. Corresponding values for fish treated for five consecutive days and by sequential feeding were 2.2 ± 2.3 and 1.7 ± 0.7 μg mL−1, respectively.